"10.1371_journal.pone.0068346","plos one","2013-07-04T00:00:00Z","Xu Wen Ng; Yingying Huang; Horng H Chen; John C Burnett; Freddy Y C Boey; Subbu S Venkatraman","School of Materials Science & Engineering, Nanyang Technological University, Singapore, Singapore; Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minnesota, United States of America","Conceived and designed the experiments: XWN YH SSV HHC JCB FYCB. Performed the experiments: XWN. Analyzed the data: XWN YH SSV. Contributed reagents/materials/analysis tools: HHC JCB FYCB. Wrote the paper: XWN YH SSV.","Cenderitide (CD-NP) has been licensed by the Mayo Clinic to Nile Therapeutics. Co-author Dr. Burnett is Chair of Nile Therapeutics Scientific Advisory Board. There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","07","Xu Wen Ng","XWN",6,TRUE,6,1,3,3,TRUE,TRUE,FALSE,0,NA,FALSE
